{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:37:00Z","timestamp":1793702220128,"version":"4.5.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1241,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The optimal treatment for severe aortic valve disease complicated with moderate function mitral regurgitation (FMR) remains controversial. Although isolated surgical aortic valve replacement (SAVR) is reasonable, previous studies also show that moderate FMR might deteriorate after surgical treatment and result in poorer prognosis. Because the left ventricular remodelling plays a critical role in the development of FMR, these patients might potentially benefit from the administration of \u03b2-blocker (BB). Unfortunately, relevant clinical evidence is lacking. This study aimed to investigate the impact of post-operative administration of BB on the outcomes of moderate FMR patients undergoing isolated SAVR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-centre cohort study, patients who underwent isolated SAVR and complicated with pre-operative moderate FMR during 2010 and 2019 at our centre were retrospectively recruited. Patients were divided into two groups according to postoperative administration of BB (BB group vs. control group). The cumulative survival rates were calculated using the Kaplan\u2013Meier method and tested by the log-rank test, followed by inverse probability treatment weighting (IPTW) analysis to further control the between-group imbalances. The primary outcome was the major adverse cardiovascular and cerebrovascular events (MACCE), a composite endpoint of all-cause death, repeat heart valve surgery, non-fatal myocardial infarction, stroke, and hospitalization for heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 165 patients were enrolled, 57 (34.6%) of whom were female, and the mean age was 59.2 \u00b1 12.2 years. Eighty (48.5%) patients received post-operative BB therapy. The median follow-up time was 18.4 months. The administration of BB was not associated with lower risk of MACCE [hazard ratio (HR): 0.68, 95% confidence interval (CI): 0.29\u20131.62, P = 0.388] or all-cause death (HR: 1.03, 95% CI: 0.30\u20130.56, P = 0.967). In the IPTW dataset, the total number of patients were 326.89, and the outcomes regarding the risk of MACCE (HR: 0.79, 95% CI: 0.31\u20131.97, P = 0.607) and all-cause death (HR: 1.33, 95% CI:0.35\u20135.05, P = 0.674) were in line with the unmatched analysis. The follow-up echocardiographic results were available for 72.2% of the overall cohort, and the use of BB was observed to be associated with higher improvement rate of follow-up FMR according to the IPTW analysis (92.2% vs. 98.3%, P = 0.033).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The administration of BB after SAVR was not associated with lower risk of MACCE for patients of severe aortic valve disease complicated with moderate FMR, but was potentially beneficial for improving FMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14053","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T05:24:20Z","timestamp":1657689860000},"page":"3317-3326","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of \u03b2-Blocker on Patients with Moderate Functional Mitral Regurgitation Undergoing Surgical Aortic Valve Replacement"],"prefix":"10.1093","volume":"9","author":[{"given":"Xieraili","family":"Tiemuerniyazi","sequence":"first","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Nan","sequence":"additional","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangwu","family":"Song","sequence":"additional","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Yang","sequence":"additional","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[{"name":"Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"2026012114161177100_ehf214053-bib-0001","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.0886-0440.2004.00362.x","article-title":"Does functional mitral regurgitation improve with isolated aortic valve replacement?","volume":"19","author":"Moazami","year":"2004","journal-title":"J Card Surg"},{"key":"2026012114161177100_ehf214053-bib-0002","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2026012114161177100_ehf214053-bib-0003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/icvts\/ivw212","article-title":"Do we have to operate on moderate functional mitral regurgitation during aortic valve replacement for aortic stenosis?","volume":"23","author":"Kowalowka","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026012114161177100_ehf214053-bib-0004","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1540-8191.2009.00965.x","article-title":"Is concomitant surgery for moderate functional mitral regurgitation indicated during aortic valve replacement for aortic stenosis? A systematic review and evidence-based recommendations","volume":"25","author":"Alghamdi","year":"2010","journal-title":"J Card Surg"},{"key":"2026012114161177100_ehf214053-bib-0005","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1532\/HSF98.20121113","article-title":"What happens to functional mitral regurgitation after aortic valve replacement for aortic stenosis?","volume":"16","author":"Wyler","year":"2013","journal-title":"Heart Surg Forum"},{"key":"2026012114161177100_ehf214053-bib-0006","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jtcvs.2008.11.015","article-title":"Management of moderate functional mitral regurgitation at the time of aortic valve replacement: Is concomitant mitral valve repair necessary?","volume":"137","author":"Wan","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012114161177100_ehf214053-bib-0007","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.athoracsur.2011.02.065","article-title":"Fate of functional mitral regurgitation and predictors of persistent mitral regurgitation after isolated aortic valve replacement","volume":"92","author":"Joo","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2026012114161177100_ehf214053-bib-0008","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.athoracsur.2011.05.060","article-title":"Long-term clinical impact of functional mitral regurgitation after aortic valve replacement","volume":"92","author":"Jeong","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2026012114161177100_ehf214053-bib-0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13019-018-0760-3","article-title":"Is isolated aortic valve replacement sufficient to treat concomitant moderate functional mitral regurgitation? A propensity-matched analysis","volume":"13","author":"Sorabella","year":"2018","journal-title":"J Cardiothorac Surg"},{"key":"2026012114161177100_ehf214053-bib-0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10741-013-9417-4","article-title":"A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling","volume":"19","author":"Yang","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2026012114161177100_ehf214053-bib-0011","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001269","article-title":"Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry","volume":"7","author":"Saito","year":"2020","journal-title":"Open Heart"},{"key":"2026012114161177100_ehf214053-bib-0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.athoracsur.2020.04.127","article-title":"Association between \u03b2-blockers and outcome of coronary artery bypass grafting: Before and after 1 year","volume":"111","author":"Park","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2026012114161177100_ehf214053-bib-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000481250","article-title":"Impact of beta-blockade on cardiac events in patients with chronic severe nonischemic mitral regurgitation","volume":"139","author":"Supino","year":"2018","journal-title":"Cardiology"},{"key":"2026012114161177100_ehf214053-bib-0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2019.11.002","article-title":"STROCSS 2019 guideline: Strengthening the reporting of cohort studies in surgery","volume":"72","author":"Agha","year":"2019","journal-title":"Int J Surg"},{"key":"2026012114161177100_ehf214053-bib-0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ejcts\/ezs676","article-title":"Management of moderate secondary mitral regurgitation at the time of aortic valve surgery","volume":"44","author":"Coutinho","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012114161177100_ehf214053-bib-0016","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11748-019-01110-w","article-title":"Risk factors for residual mitral regurgitation after aortic valve replacement in patients with severe aortic valve stenosis and moderate mitral regurgitation","volume":"67","author":"Shingu","year":"2019","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2026012114161177100_ehf214053-bib-0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019240","article-title":"Beta-blocker use is associated with prevention of left ventricular remodeling in recovered dilated cardiomyopathy","volume":"10","author":"Enzan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012114161177100_ehf214053-bib-0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4070\/kcj.2018.0259","article-title":"Beta-blockers in patients with heart failure with preserved ejection fraction: Results from the Korea acute heart failure (KorAHF) registry","volume":"49","author":"Kim","year":"2019","journal-title":"Korean Circ J"},{"key":"2026012114161177100_ehf214053-bib-0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105614","article-title":"Prognostic impacts of \u03b2-blockers in acute coronary syndrome patients without heart failure treated by percutaneous coronary intervention","volume":"169","author":"Chen","year":"2021","journal-title":"Pharmacol Res"},{"key":"2026012114161177100_ehf214053-bib-0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1177\/1060028021992329","article-title":"Therapeutic controversies in the medical management of valvular heart disease","volume":"55","author":"Barry","year":"2021","journal-title":"Ann Pharmacother"},{"key":"2026012114161177100_ehf214053-bib-0021","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jtcvs.2018.12.108","article-title":"Preoperative beta-blocker use correlates with worse outcomes in patients undergoing aortic valve replacement","volume":"158","author":"Schubert","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012114161177100_ehf214053-bib-0022","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1536\/ihj.49.385","article-title":"Effect of angiotensin converting enzyme inhibitors and beta-blockers on left ventricular remodeling after coronary artery bypass graft surgery","volume":"49","author":"Maruyama","year":"2008","journal-title":"Int Heart J"},{"key":"2026012114161177100_ehf214053-bib-0023","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","article-title":"Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure","volume":"83","author":"Lowes","year":"1999","journal-title":"Am J Cardiol"},{"key":"2026012114161177100_ehf214053-bib-0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1755-5922.12196","article-title":"Targeting the sympatho-adrenergic link in chronic rheumatic mitral regurgitation: Assessing the role of oral beta-blockers","volume":"34","author":"Sahoo","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"2026012114161177100_ehf214053-bib-0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1751-7133.2010.00146.x","article-title":"Mortality reduction with beta-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypass grafting","volume":"16","author":"Lin","year":"2010","journal-title":"Congest Heart Fail"},{"key":"2026012114161177100_ehf214053-bib-0026","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"2026012114161177100_ehf214053-bib-0027","doi-asserted-by":"crossref","DOI":"10.5867\/medwave.2016.6593","article-title":"Are beta-blockers effective in heart failure with preserved ejection fraction?","volume":"16","author":"Alegr\u00eda","year":"2016","journal-title":"Medwave"},{"key":"2026012114161177100_ehf214053-bib-0028","article-title":"Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction","volume":"5","author":"Martin","year":"2021","journal-title":"Cochrane Database Syst Rev"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/5\/3317\/65352053\/eschf_9_5_3317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/5\/3317\/65352053\/eschf_9_5_3317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:19:24Z","timestamp":1769023164000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/5\/3317\/8323065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,7,13]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14053","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"2021-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}